Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team
03 août 2023 09h05 HE
|
Trxade Health, Inc.
Forbes Fisher Appointed as Chief Operating Officer.Dr. Eugenio Bortone Appointed as Chief Innovation & Food Technology Officer. TAMPA, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH,...
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.
31 juil. 2023 08h35 HE
|
Trxade Health, Inc.
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced the closing of the previously announced...
TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.
14 juil. 2023 16h30 HE
|
Trxade Health, Inc.
NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated...
Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger Agreement to Create a Global Strategic Platform for Food and Healthy Snack Marketplace and Distribution
30 juin 2023 08h05 HE
|
Trxade Health, Inc.
NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products and distribution capabilities, announced today that it has signed a...
TRxADE HEALTH, Inc. Issues Correction to Press Release Announcing its Anticipated Combination with Superlatus, Inc. (Correction Notice)
23 juin 2023 16h40 HE
|
Trxade Health, Inc.
NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ:MEDS) (“TRxADE”), a pharmaceutical exchange platform, today announced a correction to its press release issued on Friday, June...
Superlatus, Inc. to Combine with TRxADE HEALTH, Inc., to Create a Global Food Consolidation Platform
23 juin 2023 08h05 HE
|
Trxade Health, Inc.
NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products and distribution capabilities, has signed a binding letter of intent (the...
TRxADE Health, Inc.’s Board of Directors Approves Reverse Stock Split
21 juin 2023 12h36 HE
|
Trxade Health, Inc.
Lutz, Florida, June 21, 2023 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (Nasdaq: MEDS) (the “Company”), today announced that its board of directors has approved a 1-for-15 reverse stock split of its...
TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results
15 mai 2023 16h15 HE
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, May 15, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the “Company”), a...
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results
07 nov. 2022 16h30 HE
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, Nov. 07, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the...
Bonum Health™, LLC (a TRxADE HEALTH Company) Strikes Strategic Business-to-Business (B2B) Telemedicine Services Agreement with Insurance Brokerage Firm(s) for Small-to-Medium Business (SMB) Employer Groups
25 oct. 2022 08h30 HE
|
Trxade Health, Inc.
TAMPA, FL, Oct. 25, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)(“TRxADE” or the “Company”) an integrated drug procurement, delivery, and healthcare platform, today announced that...